Surowy C S, Berger N A
Biochim Biophys Acta. 1985 Nov 8;832(1):33-45. doi: 10.1016/0167-4838(85)90171-2.
We have identified a system in human lymphocytes which proteolytically cleaves poly(ADPribose) polymerase to specific fragments of molecular weight 96 000, 79 000 and 62 000-60 000. This proteolytic processing is dependent on two different classes of proteinase. One of these proteinases is a serine proteinase, since the processing is inhibited by phenylmethylsulfonyl fluoride, antipain, soybean trypsin inhibitor and diisopropylfluorophosphate, the other is a cathepsin D-like proteinase, since processing is also inhibited by pepstatin A. The processing that occurs in permeabilized cells can be simulated in vitro by treating purified poly(ADPribose) polymerase with trypsin, but not by treating the polymerase with cathepsin D. Since processing at the cellular level is blocked by inhibitors of either of the two proteinases, but only trypsin could cleave the purified polymerase, this suggests that in the cell the action of the cathepsin D-like proteinase is a prerequisite for cleavage of poly(ADPribose) polymerase by the serine proteinase. Thus, a pathway involving sequential action of these proteinases may exist. Proteolysis in permeabilized human lymphocytes is stimulated by nucleotides containing a pyrophosphate group, such as 5',5'''-P1,P4-tetraphosphate and ATP, or by pyrophosphate itself. In contrast, nucleotides containing only a single phosphate, such as AMP and cyclic AMP, or inorganic sodium phosphate, do not show this stimulation of proteolysis. These results suggest that a pyrophosphate linkage is the minimum molecular requirement for stimulation of proteolytic processing of poly(ADPribose) polymerase. Proteolytic processing of poly(ADPribose) polymerase is independent of ADPribosylation. Following proteolysis, specific fragments of the polymerase, particularly the 62 000-60 000 molecular weight fragment(s), are still capable of being ADPribosylated.
我们已在人淋巴细胞中鉴定出一个系统,该系统能将聚(ADP - 核糖)聚合酶蛋白水解切割成分子量为96000、79000和62000 - 60000的特定片段。这种蛋白水解过程依赖于两类不同的蛋白酶。其中一种蛋白酶是丝氨酸蛋白酶,因为该过程受到苯甲基磺酰氟、抗蛋白酶、大豆胰蛋白酶抑制剂和二异丙基氟磷酸的抑制;另一种是组织蛋白酶D样蛋白酶,因为该过程也受到胃蛋白酶抑制剂A的抑制。在通透细胞中发生的这种切割过程,可通过用胰蛋白酶处理纯化的聚(ADP - 核糖)聚合酶在体外模拟,但用组织蛋白酶D处理聚合酶则无法模拟。由于细胞水平的切割过程被这两种蛋白酶中任何一种的抑制剂所阻断,但只有胰蛋白酶能切割纯化的聚合酶,这表明在细胞中,组织蛋白酶D样蛋白酶的作用是丝氨酸蛋白酶切割聚(ADP - 核糖)聚合酶的前提条件。因此,可能存在一条涉及这些蛋白酶顺序作用的途径。通透的人淋巴细胞中的蛋白水解受到含焦磷酸基团的核苷酸(如5',5'''-P1,P4 - 四磷酸和ATP)或焦磷酸本身的刺激。相比之下,仅含单个磷酸的核苷酸(如AMP和环AMP)或无机磷酸钠则不会显示出这种对蛋白水解的刺激作用。这些结果表明,焦磷酸键是刺激聚(ADP - 核糖)聚合酶蛋白水解过程的最低分子要求。聚(ADP - 核糖)聚合酶的蛋白水解过程与ADP核糖基化无关。蛋白水解后,聚合酶的特定片段,特别是分子量为62000 - 60000的片段,仍能够被ADP核糖基化。